AstraZeneca reported $1.64B in Net Income for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US USD 3.95B 3.03B
Alcon AG ALC:SW USD 116M 32M
Amgen AMGN:US USD 2.14B 826M
Artemis Alpha ATS:LN GBP -26769000 16.52M
AstraZeneca AZN:LN USD 1.64B 1.28B
AstraZeneca AZN:SS USD 1.64B 1.28B
Astrazeneca AZN:US USD 1.64B 1.28B
Bayer BAYN:GR EUR 546M 844M
Biogen BIIB:US USD 1.13B 76.7M
Bristol Myers Squibb BMY:US USD 1.61B 185M
Eli Lilly And LLY:US USD 1.45B 499.2M
Fresenius FRE:GR EUR 322M 61M
Fresenius Medical Care FME:GR EUR 230M 83M
Galapagos GLPG:NA EUR 21.55M 40.58M
Genmab GEN:DC DKK 2.58B 691M
Gilead Sciences GILD:US USD 1.79B 645M
GlaxoSmithKline GSK:LN GBP 10.32B 9.48B
Hikma Pharmaceutical HIK:LN USD 173M 0
Lonza Group LONN:SW CHF 492M 2.13B
Merck MRK:GR EUR 923M 56M
Merk MRK:US USD 3.25B 696M
Novartis NOVN:VX USD 1.57B 121M
Orion ORNBV:FH EUR 194.5M 128.4M
Pfizer PFE:US USD 8.61B 1.3B
Philips PHIA:NA EUR -1329000000 1.31B
Recordati REC:IM EUR 90.05M 35.37M
Regeneron Pharmaceuticals REGN:US USD 1.32B 463.6M